2025-04-012026-03-312026-03-31false14570039THE MERICOURT NURSERY LIMITED2026-07-23falseiso4217:GBPxbrli:pure145700392025-03-31145700392026-03-31145700392025-04-012026-03-31145700392024-03-31145700392025-03-31145700392024-04-012025-03-3114570039bus:SmallEntities2025-04-012026-03-3114570039bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3114570039bus:FullAccounts2025-04-012026-03-3114570039bus:PrivateLimitedCompanyLtd2025-04-012026-03-3114570039core:WithinOneYear2026-03-3114570039core:AfterOneYear2026-03-3114570039core:WithinOneYear2025-03-3114570039core:AfterOneYear2025-03-3114570039core:ShareCapital2026-03-3114570039core:SharePremium2026-03-3114570039core:RevaluationReserve2026-03-3114570039core:OtherReservesSubtotal2026-03-3114570039core:RetainedEarningsAccumulatedLosses2026-03-3114570039core:ShareCapital2025-03-3114570039core:SharePremium2025-03-3114570039core:RevaluationReserve2025-03-3114570039core:OtherReservesSubtotal2025-03-3114570039core:RetainedEarningsAccumulatedLosses2025-03-3114570039core:LandBuildings2026-03-3114570039core:PlantMachinery2026-03-3114570039core:Vehicles2026-03-3114570039core:FurnitureFittings2026-03-3114570039core:OfficeEquipment2026-03-3114570039core:NetGoodwill2026-03-3114570039core:IntangibleAssetsOtherThanGoodwill2026-03-3114570039core:ListedExchangeTraded2026-03-3114570039core:UnlistedNon-exchangeTraded2026-03-3114570039core:LandBuildings2025-03-3114570039core:PlantMachinery2025-03-3114570039core:Vehicles2025-03-3114570039core:FurnitureFittings2025-03-3114570039core:OfficeEquipment2025-03-3114570039core:NetGoodwill2025-03-3114570039core:IntangibleAssetsOtherThanGoodwill2025-03-3114570039core:ListedExchangeTraded2025-03-3114570039core:UnlistedNon-exchangeTraded2025-03-3114570039core:LandBuildings2025-04-012026-03-3114570039core:PlantMachinery2025-04-012026-03-3114570039core:Vehicles2025-04-012026-03-3114570039core:FurnitureFittings2025-04-012026-03-3114570039core:OfficeEquipment2025-04-012026-03-3114570039core:NetGoodwill2025-04-012026-03-3114570039core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3114570039core:ListedExchangeTraded2025-04-012026-03-3114570039core:UnlistedNon-exchangeTraded2025-04-012026-03-3114570039core:MoreThanFiveYears2025-04-012026-03-3114570039core:Non-currentFinancialInstruments2026-03-3114570039core:Non-currentFinancialInstruments2025-03-3114570039dpl:CostSales2025-04-012026-03-3114570039dpl:DistributionCosts2025-04-012026-03-3114570039core:LandBuildings2025-04-012026-03-3114570039core:PlantMachinery2025-04-012026-03-3114570039core:Vehicles2025-04-012026-03-3114570039core:FurnitureFittings2025-04-012026-03-3114570039core:OfficeEquipment2025-04-012026-03-3114570039dpl:AdministrativeExpenses2025-04-012026-03-3114570039core:NetGoodwill2025-04-012026-03-3114570039core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3114570039dpl:GroupUndertakings2025-04-012026-03-3114570039dpl:ParticipatingInterests2025-04-012026-03-3114570039dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3114570039core:ListedExchangeTraded2025-04-012026-03-3114570039dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3114570039core:UnlistedNon-exchangeTraded2025-04-012026-03-3114570039dpl:CostSales2024-04-012025-03-3114570039dpl:DistributionCosts2024-04-012025-03-3114570039core:LandBuildings2024-04-012025-03-3114570039core:PlantMachinery2024-04-012025-03-3114570039core:Vehicles2024-04-012025-03-3114570039core:FurnitureFittings2024-04-012025-03-3114570039core:OfficeEquipment2024-04-012025-03-3114570039dpl:AdministrativeExpenses2024-04-012025-03-3114570039core:NetGoodwill2024-04-012025-03-3114570039core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114570039dpl:GroupUndertakings2024-04-012025-03-3114570039dpl:ParticipatingInterests2024-04-012025-03-3114570039dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114570039core:ListedExchangeTraded2024-04-012025-03-3114570039dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114570039core:UnlistedNon-exchangeTraded2024-04-012025-03-3114570039core:NetGoodwill2026-03-3114570039core:IntangibleAssetsOtherThanGoodwill2026-03-3114570039core:LandBuildings2026-03-3114570039core:PlantMachinery2026-03-3114570039core:Vehicles2026-03-3114570039core:FurnitureFittings2026-03-3114570039core:OfficeEquipment2026-03-3114570039core:AfterOneYear2026-03-3114570039core:WithinOneYear2026-03-3114570039core:ListedExchangeTraded2026-03-3114570039core:UnlistedNon-exchangeTraded2026-03-3114570039core:ShareCapital2026-03-3114570039core:SharePremium2026-03-3114570039core:RevaluationReserve2026-03-3114570039core:OtherReservesSubtotal2026-03-3114570039core:RetainedEarningsAccumulatedLosses2026-03-3114570039core:NetGoodwill2025-03-3114570039core:IntangibleAssetsOtherThanGoodwill2025-03-3114570039core:LandBuildings2025-03-3114570039core:PlantMachinery2025-03-3114570039core:Vehicles2025-03-3114570039core:FurnitureFittings2025-03-3114570039core:OfficeEquipment2025-03-3114570039core:AfterOneYear2025-03-3114570039core:WithinOneYear2025-03-3114570039core:ListedExchangeTraded2025-03-3114570039core:UnlistedNon-exchangeTraded2025-03-3114570039core:ShareCapital2025-03-3114570039core:SharePremium2025-03-3114570039core:RevaluationReserve2025-03-3114570039core:OtherReservesSubtotal2025-03-3114570039core:RetainedEarningsAccumulatedLosses2025-03-3114570039core:NetGoodwill2024-03-3114570039core:IntangibleAssetsOtherThanGoodwill2024-03-3114570039core:LandBuildings2024-03-3114570039core:PlantMachinery2024-03-3114570039core:Vehicles2024-03-3114570039core:FurnitureFittings2024-03-3114570039core:OfficeEquipment2024-03-3114570039core:AfterOneYear2024-03-3114570039core:WithinOneYear2024-03-3114570039core:ListedExchangeTraded2024-03-3114570039core:UnlistedNon-exchangeTraded2024-03-3114570039core:ShareCapital2024-03-3114570039core:SharePremium2024-03-3114570039core:RevaluationReserve2024-03-3114570039core:OtherReservesSubtotal2024-03-3114570039core:RetainedEarningsAccumulatedLosses2024-03-3114570039core:AfterOneYear2025-04-012026-03-3114570039core:WithinOneYear2025-04-012026-03-3114570039core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3114570039core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3114570039core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3114570039core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3114570039core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3114570039core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3114570039core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114570039core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114570039core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3114570039core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3114570039core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3114570039core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3114570039core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3114570039core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3114570039core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3114570039core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3114570039core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3114570039core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3114570039core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114570039core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114570039core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114570039core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114570039core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114570039core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114570039core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114570039core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114570039core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114570039bus:Director12025-04-012026-03-31

THE MERICOURT NURSERY LIMITED

Registered Number
14570039
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

THE MERICOURT NURSERY LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Director

RANI, Barkha

Registered Address

Mericourt Sandyforth Lane
Lightfoot Green
Preston
PR4 0AL

Registered Number

14570039 (England and Wales)
THE MERICOURT NURSERY LIMITED
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets4148,04734,084
148,04734,084
Current assets
Debtors537,47726,825
Cash at bank and on hand13,888207,097
51,365233,922
Creditors amounts falling due within one year6(47,831)(51,079)
Net current assets (liabilities)3,534182,843
Total assets less current liabilities151,581216,927
Creditors amounts falling due after one year7(100,000)(100,000)
Provisions for liabilities8(5,486)(6,601)
Net assets46,095110,326
Capital and reserves
Called up share capital100100
Profit and loss account45,995110,226
Shareholders' funds46,095110,326
The financial statements were approved and authorised for issue by the Director on 23 July 2026, and are signed on its behalf by:
RANI, Barkha
Director
Registered Company No. 14570039
THE MERICOURT NURSERY LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Plant and machinery25
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Government grants or assistance
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model and the performance model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset. Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.
2.Average number of employees

20262025
Average number of employees during the year2520
3.Deferred tax
Increases in the UK Corporation tax rate from 19% to 25% (19% effective from 1 April 2017, and 25% effective from 1 April 2023) have been substantively enacted. This will impact the company's future tax charge accordingly. The value of the deferred tax assets at the balance sheet date has been calculated using the applicable rate when the asset is expected to be realised.
4.Tangible fixed assets

Land & buildings

Plant & machinery

Total

£££
Cost or valuation
At 01 April 257,68035,11642,796
Additions118,4222,855121,277
At 31 March 26126,10237,971164,073
Depreciation and impairment
At 01 April 25-8,7128,712
Charge for year-7,3157,315
Other adjustments-(1)(1)
At 31 March 26-16,02616,026
Net book value
At 31 March 26126,10221,945148,047
At 31 March 257,68026,40434,084
5.Debtors: amounts due within one year

2026

2025

££
Amounts owed by group undertakings35,89925,899
Other debtors1,578926
Total37,47726,825
6.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables1,4531,008
Taxation and social security39,99944,878
Other creditors6,2551,443
Accrued liabilities and deferred income1243,750
Total47,83151,079
7.Creditors: amounts due after one year

2026

2025

££
Other creditors100,000100,000
Total100,000100,000
8.Provisions for liabilities

2026

2025

££
Net deferred tax liability (asset)5,4866,601
Total5,4866,601
9.Directors advances, credits and guarantees
As at 31 March 2025, the company owed the director (B Rani) £6,253 (2025: £1,443 ) in respect of the balance on her director's loan account. This loan is interest free and is repayable to the director on demand.
10.Related party transactions
At 31 March 2026, the following amounts were owed to the company by fellow group undertakings under common control: Related party: £ Kairavi Property Services Ltd 25,799 KBA Holdings Ltd 10,100 Total 35,899 These balances are included within debtors balance as amounts owed by group undertakings. The balances are unsecured, interest-free, and repayable on demand.
11.Controlling party
The company is a subsidiary of KBA Holdings Limited whose registered office address is Mericourt Sandyforth Lane, Lightfoot Green, Preston, England, PR4 0AL. KBA Holdings Limited is controlled by Mr Arun Kumar and Mrs Barkha Rani.